Comparative kinetics of SARS-CoV-2 anti-spike protein RBD IgGs and neutralizing antibodies in convalescent and naïve recipients of the BNT162b2 mRNA vaccine versus COVID-19 patients

BACKGROUND: Coronavirus SARS-CoV-2, the causative agent of COVID-19, has caused a still evolving global pandemic. Given the worldwide vaccination campaign, the understanding of the vaccine-induced versus COVID-19-induced immunity will contribute to adjusting vaccine dosing strategies and speeding-up...

Descripción completa

Detalles Bibliográficos
Autores principales: Trougakos, Ioannis P., Terpos, Evangelos, Zirou, Christina, Sklirou, Aimilia D., Apostolakou, Filia, Gumeni, Sentiljana, Charitaki, Ioanna, Papanagnou, Eleni-Dimitra, Bagratuni, Tina, Liacos, Christine-Ivy, Scorilas, Andreas, Korompoki, Eleni, Papassotiriou, Ioannis, Kastritis, Efstathios, Dimopoulos, Meletios A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8380479/
https://www.ncbi.nlm.nih.gov/pubmed/34420521
http://dx.doi.org/10.1186/s12916-021-02090-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8380479/
https://www.ncbi.nlm.nih.gov/pubmed/34420521
http://dx.doi.org/10.1186/s12916-021-02090-6

Ejemplares similares